NeuroSAE: April 2024
Course Description
- Written by neurologists for neurologists.
- Questions based on the ABPN content outline for the cognitive expertise component (Part III) of Continuing Certification (CC).
- Assess your areas of strengths and weaknesses.
- Compare your performance to other neurologists.
- Up to 20 percent of questions with images.
- Convenient online format: take on your own time, at your own pace.
- Offers opportunity to earn 2 self-assessment credits of CME per exam.
- Fulfill both the self-assessment component and the CME component of your Continuing Certification (CC).
- The AAN has a minimum performance pass rate of 70 percent in order to comply with the AMA PRA Category 1 Credit™ requirements.
- Participants can retake the test if they do not pass the first time.
Learning Objectives
As a result of this self-assessment activity, the learner will be able to:
- Identify major clinical areas of neurology that require more focused study and review.
- Evaluate areas of strength and weakness and consult educational resources for self-education and improvement.
- Apply new and reviewed information derived from the exam and resources into clinical practice to provide optimal patient care.
Date of Release
April 10, 2024.
Duration Statement: This exam is eligible for 2 self-assessment CME credits for three years from the release date.
Duration Statement: This exam is eligible for 2 self-assessment CME credits for three years from the release date.
Confidentiality of Data
All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved. See complete Terms of Use.
The American Academy of Neurology (AAN) is not requesting any individually identifiable information. The data you submit to the AAN through the NeuroSAE® is de-identified, as it neither identifies nor provides a reasonable basis to identify an individual. All information submitted to the AAN through NeuroSAE® is confidential. Data may be used and presented anonymously and in aggregate by the AAN.
Content Outline
|
|
ACCREDITATION
The American Academy of Neurology Institute (AANI), a subsidiary of the American Academy of Neurology (AAN), is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT
The American Academy of Neurology Institute (AANI) designates this enduring material for a maximum of 2
AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA CREDIT DESIGNATION STATEMENT
The NeuroSAE program is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Calgary Office of Continuing Medical Education and Professional Development. Program expires August 4, 2026. Remember to visit MAINPORT to record your learning and outcomes. Canadian participants may claim a maximum of 2 hours (credits are automatically calculated). Participants cannot claim credit for issues prior to July 2017.
ABPN APPROVED ACTIVITYThe American Board of Psychiatry and Neurology (ABPN) has reviewed and approved this program for CME and as part of a Self-Assessment program, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of Continuing Certification (CC).
FACULTY & DISCLOSURESNote: All relevant financial relationships have been mitigated.Patrick Landazuri, MD Chair Associate Professor of Neurology University of Kansas Medical Center Kansas City, KS *Dr. Landazuri has nothing to disclose. Hossein Ansari, MD, FAAN Director of Headache Clinic University of California, San Diego San Diego, CA *Dr. Ansari has nothing to disclose. Sherri Braksick, MD Neurointensivist Mayo Clinic Rochester, MN *Dr. Braksick has nothing to disclose. William Cheshire, MD, FAAN Professor of Neurology, Mayo Clinic Jacksonville, Florida *Dr. Cheshire has received personal compensation from Oxford University Press, Elsevier, Biohaven, Trinity International University. Dr. Cheshire has non-compensated relationships as a Board of Directors with American Autonomic Society and as an Associate Editor with Clinical Autonomic Research that are relevant to AAN interests or activities. Collin Culbertson, MD Staff Neurologist (Vascular) Lahey Hospital & Medical Center Burlington, MA *Dr. Culbertson has nothing to disclose. Andres F. Deik, MD, MSEd Assistant Professor of Clinical Neurology University of Pennsylvania Philadelphia, PA *Dr. Deik Acosta Madiedo has received personal compensation for serving as a Consultant for Amneal Pharmaceuticals. Dr. Deik Acosta Madiedo has received personal compensation for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Sunovion Pharmaceuticals, Revance Therapeutics, Insightec, Teva Pharmaceuticals, Cerevel Therapeutics, and Prevail Therapeutics. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care. . Tamara Kaplan, MD Assistant Professor Neurology Brigham and Women's Hospital Boston, MA *Dr. Kaplan has received personal compensation for serving as a Consultant for Novartis, Genentech, Bristol Myers Squibb, and Biogen. Jessica Doyle Lee, MD, FAAN, FANA Vascular Neurology Fellowship Director Associate Professor of Neurology University of Kentucky College of Medicine Lexington, KY *Dr. Lee has received personal compensation for serving as an employee of Christiana Care Hospital and the American Academy of Neurology. Bhavana Patel, DO Clinical Assistant Professor, Neurology & Psychiatry University of Iowa Iowa City, IA *Dr. Patel has nothing to disclose. Swetha Renati, MD Associate Professor of Neurology Director, Vascular Neurology Fellowship University of South Florida Tampa, FL *Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ischemia View. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Renati has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wettermark Keith, LLC. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a Moderator with PRIME Education. Maisha Robinson, MD, MS, FAAN Neurologist Mayo Clinic Jacksonville, FL *The institution of Dr. Robinson has received research support from Florida Department of Health. The institution of Dr. Robinson has received research support from Community Foundation. Dr. Robinson has received publishing royalties from a publication relating to health care. Dr. Robinson has received personal compensation in the range of $5,000-$9,999 for serving as a Longitudinal Knowledge Assessment committee on hospice and palliative care member with American Board of Internal Medicine. Dr. Robinson has a non-compensated relationship as a President-Elect with International Neuropalliative Care Society that is relevant to AAN interests or activities. Harini Sarva, MD Assistant Professor, Department of Neurology Associate Program Director for Adult Neurology Residency Program Behavioral Neurology Fellowship Director Weill Cornell Medical Center New York, NY *Dr. Sarva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sarva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Covance. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. HyungSub Shim, MD Clinical Assistant Professor, Neurology & Psychiatry University of Iowa Iowa City, IA *Dr. Shim has nothing to disclose. Sheetal Shroff, MD Neurologist Houston Methodist Hospital Houston, TX *Dr. Shroff has received personal compensation from Alnylam. Jayashree Sundararajan, MD Neurologist Cleveland Clinic Neurological Institute Cleveland, OH *Dr. Sundararajan has nothing to disclose. Uzma Usman, MBBS Assistant Professor Yale School of Medicine New Haven, CT *Dr. Usman has nothing to disclose. Utku Uysal, MD Assistant Professor of Neurology Kansas University Kansas City, KS *Dr. Uysal has nothing to disclose. NEUROSAE STAFFXiaoyu Sun, Associate Director, eLearningMinneapolis, MN *Ms. Sun has nothing to disclose. Lynne Shindoll, MA, Manager, eLearning Minneapolis, MN *Ms. Shindoll has nothing to disclose. Tessa Dahlgren, eLearning & Production Program Manager Minneapolis, MN *Ms. Dahlgren has nothing to disclose. *Relationship Disclosure |